Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 3811 AL 3825

Tackling the neurological manifestations in Wilson's disease - currently available treatment options

Litwin T, Dusek P, Antos A, Członkowska A, Bembenek J.

Expert Rev Neurother. 2023 Jul-Dec;23(12):1249-1259. doi: 10.1080/14737175.2023.2268841. Epub 2023 Dec 15.

Understanding Sleep Regulation in Normal and Pathological Conditions, and Why It Matters

Nollet M, Franks NP, Wisden W.

J Huntingtons Dis. 2023;12(2):105-119. doi: 10.3233/JHD-230564.

Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases

Rani N, Alam MM, Jamal A, Bin Ghaffar U, Parvez S.

Ageing Res Rev. 2023 Nov;91:102036. doi: 10.1016/j.arr.2023.102036. Epub 2023 Aug 19.

Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities

Brem AK, Kuruppu S, de Boer C, Muurling M, Diaz-Ponce A, Gove D, Curcic J, Pilotto A, Ng WF, Cummins N, Malzbender K, Nies VJM, Erdemli G, Graeber J, Narayan VA, Rochester L, Maetzler W, Aarsland D.

Front Neurol. 2023 Jun 15;14:1210974. doi: 10.3389/fneur.2023.1210974. eCollection 2023.

Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System

Zhang H, Dai S, Yang Y, Wei J, Li X, Luo P, Jiang X.

Biomolecules. 2023 Apr 24;13(5):735. doi: 10.3390/biom13050735.

A 20-Year Systematic Review of the 'Reading the Mind in the Eyes' Test across Neurodegenerative Conditions

Stafford O, Gleeson C, Egan C, Tunney C, Rooney B, O'Keeffe F, McDermott G, Baron-Cohen S, Burke T.

Brain Sci. 2023 Aug 31;13(9):1268. doi: 10.3390/brainsci13091268.

Endocytic pathways of pathogenic protein aggregates in neurodegenerative diseases

Hivare P, Mujmer K, Swarup G, Gupta S, Bhatia D.

Traffic. 2023 Oct;24(10):434-452. doi: 10.1111/tra.12906. Epub 2023 Jul 1.

Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases

Shen H, Xu X, Bai Y, Wang X, Wu Y, Zhong J, Wu Q, Luo Y, Shang T, Shen R, Xi M, Sun H.

Eur J Med Chem. 2023 May 5;251:115258. doi: 10.1016/j.ejmech.2023.115258. Epub 2023 Mar 8.

Implications from proteomic studies investigating circadian rhythm disorder-regulated neurodegenerative disease pathology

Liu W, Ma R, Sun C, Xu Y, Liu Y, Hu J, Ma Y, Wang D, Wen D, Yu Y.

Sleep Med Rev. 2023 Aug;70:101789. doi: 10.1016/j.smrv.2023.101789. Epub 2023 May 15.

Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders

Rahman MM, Tumpa MAA, Rahaman MS, Islam F, Sutradhar PR, Ahmed M, Alghamdi BS, Hafeez A, Alexiou A, Perveen A, Ashraf GM.

Curr Neuropharmacol. 2023;21(5):1081-1099. doi: 10.2174/1570159X21666230316150559.

The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington's Disease

Bhat SA, Ahamad S, Dar NJ, Siddique YH, Nazir A.

Curr Neuropharmacol. 2023;21(4):867-889. doi: 10.2174/1570159X21666230216104621.

Catching the Culprit: How Chorea May Signal an Inborn Error of Metabolism

Ortigoza-Escobar JD.

Tremor Other Hyperkinet Mov (N Y). 2023 Oct 6;13:36. doi: 10.5334/tohm.801. eCollection 2023.

The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection

Yan J, Bading H.

Pharmaceuticals (Basel). 2023 Jul 31;16(8):1085. doi: 10.3390/ph16081085.

Case report: Clinical lycanthropy in Huntington's disease

Medford N, Sigala N.

Front Psychiatry. 2023 Jan 27;14:1089872. doi: 10.3389/fpsyt.2023.1089872. eCollection 2023.

Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

Singh S, Shukla R.

AAPS PharmSciTech. 2023 Sep 2;24(7):179. doi: 10.1208/s12249-023-02625-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias